John Kao Sells 48,899 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 48,899 shares of the business’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $17.45, for a total transaction of $853,287.55. Following the completion of the sale, the chief executive officer directly owned 1,519,480 shares of the company’s stock, valued at $26,514,926. The trade was a 3.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Alignment Healthcare Stock Down 0.8%

Shares of Alignment Healthcare stock traded down $0.13 during trading on Friday, reaching $16.99. The company had a trading volume of 1,945,321 shares, compared to its average volume of 2,945,851. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The firm’s fifty day moving average is $20.76 and its 200-day moving average is $18.73. The company has a market cap of $3.47 billion, a price-to-earnings ratio of -1,697.30, a price-to-earnings-growth ratio of 2.50 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. During the same period in the previous year, the company earned ($0.16) earnings per share. Alignment Healthcare’s quarterly revenue was up 44.4% on a year-over-year basis. On average, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Piper Sandler increased their target price on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a report on Tuesday, January 6th. UBS Group lifted their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, January 14th. TD Cowen raised their target price on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a report on Friday, January 16th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. Finally, Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $24.56.

Hedge Funds Weigh In On Alignment Healthcare

Several large investors have recently bought and sold shares of ALHC. Vanguard Group Inc. lifted its holdings in shares of Alignment Healthcare by 10.9% in the fourth quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after buying an additional 1,524,218 shares during the period. Wellington Management Group LLP grew its holdings in Alignment Healthcare by 26.9% during the fourth quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock worth $277,900,000 after acquiring an additional 2,981,166 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in Alignment Healthcare by 0.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after acquiring an additional 79,268 shares during the period. Invesco Ltd. raised its position in Alignment Healthcare by 38.9% in the fourth quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock worth $122,501,000 after acquiring an additional 1,735,962 shares in the last quarter. Finally, Hood River Capital Management LLC increased its holdings in shares of Alignment Healthcare by 6.0% in the second quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company’s stock valued at $77,243,000 after buying an additional 311,424 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.